Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Minerva Neurosciences Inc (NASDAQ:NERV)

5.35
Delayed Data
As of Feb 05
 -0.08 / -1.47%
Today’s Change
4.25
Today|||52-Week Range
6.50
-11.86%
Year-to-Date
No recent news for Minerva Neurosciences Inc.

Today’s Trading

Previous close5.43
Today’s open5.46
Day’s range5.23 - 5.46
Volume9,720
Average volume (3 months)25,122
Market cap$145.3M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-1,931.82%
Earnings growth (this year)+73.68%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.92

Competitors

 Today’s
change
Today’s
% change
CPRXCatalyst Pharmaceuti...-0.12-6.32%
--China Health Group I...+0.01+5.23%
MSLIMerus Labs Internati...-0.05-3.47%
NEOSNeos Therapeutics In...-0.61-6.54%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 24, 2016
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$0.00
Annual profit (last year)-$56.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rémy Luthringer
Chief Operating Officer &
Senior Vice President
Joseph Reilly
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers